Segmented ART - The new era in ART?

Reproductive Biology

Volumn 16, Issue 2, 2016, Pages 91-103

  Ozgur, Kemal ^a   Humaidan, Peter ^b   Coetzee, Kevin ^a  

^a Antalya IVF   (Turkey)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

ART; GnRHa trigger; Iatrogenesis; Perinatal; Segmented ART

Indexed keywords

EMBRYO TRANSFER; FEMALE; HUMAN; INFERTILITY THERAPY; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES;

EMBRYO TRANSFER; FEMALE; HUMANS; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84964289030     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repbio.2016.04.001     Document Type: Review

References (100)

1. Pinborg A., Wennerholm U.B., Romundstad L.B., Loft A., Aittomaki K., Soderstrom-Anttila V., et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update 2013, 19:87-104.
2. Talaulikar V.S., Arulkumaran S. Maternal, perinatal and long-term outcomes after assisted reproductive techniques (ART): implications for clinical practice. Eur J Obstet Gynecol Reprod Biol 2013, 170:13-19.
3. Bloise E., Feuer S.K., Rinaudo P.F. Comparative intrauterine development and placental function of ART concepti: implications for human reproductive medicine and animal breeding. Hum Reprod Update 2014, 20:822-839.
4. Rimoldi S.F., Sartori C., Rexhaj E., Cerny D., von Arx R., Soria R., et al. Vascular dysfunction in children conceived by assisted reproductive technologies: underlying mechanisms and future implications. Swiss Med Wkly 2014, 144:w13973.
5. Devroey P., Polyzos N.P., Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod 2011, 26:2593-2597.
6. Baker V.L., Brown M.B., Luke B., Smith G.W., Ireland J.J. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril 2015, 104:1145-1152.
7. Fauser B.C., Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Enocrinol Metab 2003, 14:236-242.
8. Weinerman R., Mainigi M. Why we should transfer frozen instead of fresh embryos: the translational rationale. Fertil Steril 2014, 102:10-18.
9. Kyrou D., Popovic-Todorovic B., Fatemi H.M., Bourgain C., Haentjens P., Van Landuyt L., et al. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?. Hum Reprod 2009, 14:2902-2909.
10. Farhi J., Haroush A.B., Andrawus N., Pinkas H., Sapir O., Fisch B., et al. High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation. Reprod BioMed Online 2010, 21:331-337.
11. Imudia A.N., Goldman R.H., Awonuga A.O., Wright D.L., Styer A.K., Toth T.L. The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles. J Assist Reprod Genet 2014, 31:65-71.
12. Kyrou D., Al-Azemi M., Papanikolaou E.G., Donoso P., Tziomalos K., Devroey P., et al. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol 2012, 162:165-168.
13. Park J.H., Jee B.C., Kim S.H. Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles. Clin Exp Reprod Med 2015, 42:67-71.
14. Venetis C.A., Kolibianakis E.M., Bosdou J.K., Tarlatzis B.C. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update 2013, 19:433-457.
15. Bosch E., Labarta E., Crespo J., Simon C., Remoh J., Jenkins J., et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010, 25:2092-2100.
16. Hill M.J., Royster G.D., Healy M.W., Richter K.S., Levy G., DeCherney A.H., et al. Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation?. Fertil Steril 2015, 103:1477-1484.
17. Papanikolaou E.G., Bourgain C., Kolibianakis E., Tournaye H., Devroey P. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Hum Reprod 2005, 20:1541-1547.
18. Devoto L., Kohen P., Muñoz A., Strauss J.F. Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation. Reprod Biomed Online 2009, 18:19-24.
19. Humaidan P., Papanikolaou E.G., Kyrou D., Alsbjerg B., Polyzos N.P., Devroey P., et al. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reprod BioMed Online 2012, 24:134-141.
20. Fauser B.C., De Jong D., Olivennes F., Wramsby H., Tay C., Itskovitz-Eldor J., et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 2002, 87:709-715.
21. Fatemi H.M., Polyzos N.P., van Vaerenbergh I., Bourgain C., Blockeel C., Alsbjerg B., et al. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant FSH-GnRH antagonist IVF cycles. Fertil Steril 2013, 100:742-747.
22. Mainigi M.A., Olalere D., Burd I., Sapienza C., Bartolomei M., Coutifaris C. Peri-implantation hormonal milieu: elucidating mechanisms of abnormal placentation and fetal growth. Biol Reprod 2014, 90(26):1-9.
23. Galliano D., Garrido N., Serra-Serra V., Pellicer A. Difference in birth weight of consecutive sibling singletons is not found in oocyte donation when comparing fresh versus frozen embryo replacements. Fertil Steril 2015, 104:1411-1418.
24. Roque M., Lattes K., Serra S., vSola I., Psych B., Geber S., et al. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril 2013, 99:156-162.
25. Ozgur K., Berkkanoglu M., Bulut H., Humaidan P., Coetzee K. Perinatal outcomes after fresh versus vitrified-warmed blastocyst transfer - a retrospective analysis. Fertil Steril 2015, 104:899-907.
26. Labarta E., Martinez-Conejero J.A., Alama P., Horcajadas J.A., Pellicer A., Simon C., et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod 2011, 26:1813-1825.
27. Van Vaerenbergh I., Van Lommel L., Ghislain V., Int Veld P., Schuit F., Fatemi H.M., et al. In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression. Hum Reprod 2009, 24:1085-1091.
28. Humaidan P., Van Vaerenbergh I., Bourgain C., Alsbjerg B., Blockeel C., Schuit F., et al. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Hum Reprod 2012, 27:3259-3272.
29. Evans G.E., Phillipson G.T.M., Sin L., Frampton C.M.A., Kirker J.A., Bigby S.M., et al. Gene expression confirms a potentially receptive endometrium identified by histology in fertile women. Hum Reprod 2012, 27:2747-2755.
30. Garrido-Gomez T., Ruiz-Alonso M., Blesa D., Diaz-Gimeno P., Vilella F., Simon C. Profiling the gene signature of endometrial receptivity: clinical results. Fertil Steril 2013, 99:1078-1085.
31. Bourgain C., Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update 2003, 9:515-522.
32. Junovich G., Mayer Y., Azpiroz A., Daher S., Iglesias A., Zylverstein C., et al. Ovarian stimulation affects the levels of regulatory endometrial NK cells and angiogenic cytokine VEGF. Am J Reprod Immunol 2011, 65:146-153.
33. Zhu L., Li Y., Xu A. Influence of controlled ovarian hyperstimulation on uterine peristalsis in infertile women. Hum Reprod 2012, 27:2684-2689.
34. Dhont M. Single-embryo transfer. Semin Reprod Med 2001, 19:251-258.
35. Gardner D.K., Surrey E., Minjarez D., Leitz A., Stevens J., Schoolcraft W.B. Single blastocyst transfer: a prospective randomized trial. Fertil Steril 2004, 81:551-555.
36. Seppälä M. The world collaborative report on in vitro fertilization and embryo replacement: current state of the art in January 1984. Ann N Y Acad Sci 1985, 442:558-563.
37. Gardner D.K., Lane M. Culture and selection of viable blastocysts: a feasible proposition for human IVF?. Hum Reprod Update 1997, 3:367-382.
38. Gardner D.K., Vella P., Lane M., Wagley L., Schlenker T., Schoolcraft W.B. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril 1998, 69:84-88.
39. Schoolcraft W.B., Gardner D.K., Lane M., Schlenker T., Hamilton F., Meldrum D.R. Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril 1999, 72:604-609.
40. Gardner D.K., Lane M., Stevens J., Schenkler T., Schoolcraft W.B. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000, 76:1155-1158.
41. Papanikolaou E.G., Kolibianakis E.M., Tournaye H., Venetis C.A., Fatemi H., Tarlatzis B., et al. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod 2008, 23:91-99.
42. Glujovsky D., Blake D., Farquhar C., Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev 2012, 7:CD002118.
43. Maheshwari A., Kalampokas T., Davidson J., Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of blastocyst-stage versus cleavage-stage embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2013, 100:1615-1621.
44. Franasiak J.M., Dondik Y., Molinaro T.A., Hong K.H., Forman E.J., Werner M.D., et al. Blastocyst transfer is not associated with increased rates of monozygotic twins when controlling for embryo cohort quality. Fertil Steril 2015, 103:95-100.
45. Pinborg A. To transfer fresh or thawed embryos?. Semin Reprod Med 2012, 30:230-235.
46. Hernandez Torres E., Navarro-Espigares J.L., Clavero A., Lopez-Regalado M.L., Camacho-Ballesta J.A., Onieva-García M.A., et al. Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program. Fertil Steril 2015, 103:699-706.
47. Evans J., Hannan N.J., Edgell T.A., Vollenhoven B.J., Lutjen P.J., Osianlis T., et al. Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence. Hum Reprod Update 2014, 20:808-821.
48. Edgar D.H., Gook D.A. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update 2012, 18:536-554.
49. Cobo A., de los Santos M.J., Castello D., Gamiz P., Campos P., Remohí J. Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles. Fertil Steril 2012, 98:1138-1146.
50. Kuwayama M., Vajta G., Ieda S., Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod Biomed Online 2005, 11:608-614.
51. Balaban B., Urman B., Ata B., Isiklar A., Larman M.G., Hamilton R., et al. A randomized controlled study of human day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation. Hum Reprod 2008, 23:1976-1982.
52. Li Z., Wang Y.A., Ledger W., Edgar D.H., Sullivan E.A. Clinical outcomes following cryopreservation of blastocysts by vitrification or slow freezing: a population-based cohort study. Hum Reprod 2014, 29:2794-2801.
53. Groenewoud E.R., Cantineau A.E.P., Kollen B.J., Macklon N.S., Cohlen B.J. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update 2013, 19:458-470.
54. Zhu D., Zhang J., Cao S., Zhang J., Heng B.C., Huang M., et al. Vitrified-warmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cycles-time for a new embryo transfer strategy. Fertil Steril 2011, 95:1691-1695.
55. Feng G., Zhang B., Zhou H., Shu J., Gan X., Wu F., et al. Comparable clinical outcomes and live births after single vitrified-warmed and fresh blastocyst transfer. Reprod BioMed Online 2012, 25:466-473.
56. Roy T.K., Bradley C.K., Bowman M.C., McArthur S.J. Single-embryo transfer of vitrified-warmed blastocysts yields equivalent live-birth rates and improved neonatal outcomes compared with fresh transfers. Fertil Steril 2014, 101:1294-1301.
57. Ozgur K., Berkkanoglu M., Bulut H., Isikli A., Coetzee K. Higher clinical pregnancy rates from frozen-thawed blastocyst transfers compared to fresh blastocyst transfers: a retrospective matched-cohort study. J Assist Reprod Genet 2015, 32:1:483-1490.
58. Wikland M., Hardarson T., Hillensjo T., Westin C., Westlander G., Wood M., et al. Obstetric outcomes after transfer of vitrified blastocysts. Hum Reprod 2010, 25:1699-1707.
59. Shi W., Xue X., Zhang S., Zhao W., Liu S., Zhou H., et al. Perinatal and neonatal outcomes of 494 babies delivered from 972 vitrified embryo transfers. Fertil Steril 2012, 97:1338-1342.
60. Ruiz-Alonso M., Blesa D., Díaz-Gimeno P., Gomez E., Fernandez-Sanchez M., Carranza F., et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril 2013, 100:818-824.
61. Glasser S.R., Julian J., Munir M.I., Soares M.J. Biological markers during early pregnancy: trophoblastic signals of the peri-implantation period. Environ Health Perspect 1987, 74:129-147.
62. Ubaldi F., Bourgain C., Tournaye H., Smitz J., Van Steirteghem A., Devroey P. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril 1997, 67:521-526.
63. Haavaldsen C., Tanbo T., Eskild A. Placental weight in singleton pregnancies with and without assisted reproductive technology: a population study of 536 567 pregnancies. Hum Reprod 2012, 27:576-582.
64. Achache H., Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006, 12:731-746.
65. Boomsma C.M., Kavelaars A., Eijkemans M.J., Fauser B.C., Heijnen C.J., Macklon N.S. Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril 2010, 94:1764-1768.
66. Manno M., Tomei F. Can we prevent premature luteinization in IVF cycles?. Med Hypotheses 2014, 82:122-123.
67. Huang B., Hu D., Qian K., Ai J., Li Y., Jin L., et al. Is frozen embryo transfer cycle associated with a significantly lower incidence of ectopic pregnancy? An analysis of more than 30,000 cycles. Fertil Steril 2014, 102:1345-1349.
68. Li Z., Sullivan E.A., Chapman M., Farquhar C., Wang Y.A. Risk of ectopic pregnancy lowest with transfer of single frozen blastocyst. Hum Reprod 2015, 30:2048-2054.
69. Romundstad L.B., Romundstad P.R., Sunde A., von Düring V., Skjaerven R., Gunnell D., et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008, 372:737-743.
70. Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008, 89:84-91.
71. Grossman L.C., Michalakis K.G., Browne H., Payson M.D., Segars J.H. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil Steril 2010, 94:1392-1398.
72. Humaidan P., Quartarolo J., Papanikolaou E.G. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril 2010, 94:389-400.
73. Fatemi H.M., Garcia-Velasco J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger. Fertil Steril 2015, 103:870-873.
74. Itskovitz-Eldor J., Kol S., Mannaerts B., Coelingh Bennink H. First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462). Hum Reprod 1998, 13:294-295.
75. Borm G., Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000, 15:1877.
76. Humaidan P. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod Biomed Online 2009, 18:630-634.
77. Humaidan P., Kol S., Papanikolaou E.G. GnRH agonist for triggering of final oocyte maturation: time for a change of practice?. Hum Reprod Update 2011, 17:510-524.
78. Humaidan P., Ejdrup Bredkjaer H., Westergaard L.G., Yding Andersen C. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 2010, 93:847-854.
79. Humaidan P., Engmann L., Benadiva C. Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril 2015, 103:879-885.
80. Humaidan P., Bungum L., Bungum M., Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006, 13:173-178.
81. Humaidan P., Polyzos N.P., Alsbjerg B., Erb K., Mikkelsen A.L., Elbaek H.O., et al. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod 2013, 28:2511-2521.
82. Seyhan A., Ata B., Polat M., Son W.-Y., Yarali H., Dahan M.H. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IUhCG. Hum Reprod 2013, 28:2522-2528.
83. Maheshwari A., Pandey S., Shetty A., Hamilton M., Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2012, 98:368-377.
84. Sazonova A., Kallen K., Thurin-Kjellberg A., Wennerholm U.-B., Bergh C. Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Hum Reprod 2012, 27:1343-1350.
85. Davies M.J., Moore V.M., Willson K.J., Van Essen P., Priest K., Scott H., et al. Reproductive technologies and the risk of birth defects. N Engl J Med 2012, 366:1803-1813.
86. Shih W., Rushford D.D., Bourne H., Garrett C., McBain J.C., Healy D.L., et al. Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod 2008, 23:1644-1653.
87. Pinborg A., Henningsen A.A., Loft A., Malchau S.S., Forman J., Nyboe Andersen A. Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique?. Hum Reprod 2014, 29:618-627.
88. Wennerholm U.-B., Henningsen A-KA, Romundstad L.B., Bergh C., Pinborg A., Skjaerven R., et al. Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Hum Reprod 2013, 28:2545-2553.
89. Pinborg A., Loft A., Henningsen A.A., Rasmussen S., Nyboe Andersen A. Infant outcome of 957 singletons born after frozen embryo replacement: The Danish National Cohort Study 1995-2006. Fertil Steril 2010, 94:1320-1327.
90. Ishihara O., Araki R., Kuwahara A., Itakura A., Saito H., Adamson G.D. Impact of frozen-thawed single blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril 2014, 101:128-133.
91. Kalra S.K., Ratcliffe S.J., Coutifaris C., Molinaro T., Barnhart K.T. Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization. Obstet Gynecol 2011, 118:863-871.
92. Pelkonen S., Koivunen R., Gissler M., Nuojua-Huttunen S., Suikkari A.M., Hyden-Granskog C., et al. Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995-2006. Hum Reprod 2010, 25:914-923.
93. Scott R.T., Ferry K., Su J., Tao X., Scott K., Treff N.R. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril 2012, 97:870-875.
94. Díaz-Gimeno P., Ruiz-Alonso M., Blesa D., Bosch N., Martínez-Conejero J.A., Alamá P., et al. The accuracy and reproducibility of the endometrial receptivity array is superior to histology as a diagnostic method for endometrial receptivity. Fertil Steril 2013, 99:508-517.
95. El-Toukhy T., Sunkara S.K., Khalaf Y. Local endometrial injury and IVF outcome: a systematic review and meta-analysis. Reprod BioMed Online 2012, 25:345-354.
96. Nastri C.O., Ferriani R.A., Raine-Fenning N., Martins W.P. Endometrial scratching performed in the non-transfer cycle and outcome of assisted reproduction: a randomized controlled trial. Ultrasound Obstet Gynecol 2013, 42:375-382.
97. Pundir J., Pundir V., Omanwa K., Khalaf Y., El-Toukhy T. Hysteroscopy prior to the first IVF cycle: A systematic review and meta-analysis. Reprod BioMed Online 2014, 28:151-161.
98. Shapiro B.S., Daneshmand S.T., Garner F.C., Aguirre M., Hudson C. Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer. Fertil Steril 2014, 102:3-9.
99. Ozgur K., Berkkanoglu M., Bulut H., Humaidan P., Coetzee K. Agonist depot versus OCP programming of frozen embryo transfer: a retrospective analysis of freeze-all cycles. J Assist Reprod Genet 2016, 33:207-214.
100. Turner K., Reynolds-May M.F., Zitek E.M., Tisdale R.L., Carlisle A.B., Westphal L-M. Stress and anxiety scores in first and repeat IVF cycles: A Pilot Study. PLoS ONE 2013, 8:e63743.